601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
Clinical trial NCT04922151 · UNKNOWN
Trial details
- NCT number
- NCT04922151
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-04
- Primary completion
- 2023-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.